292 related articles for article (PubMed ID: 15564772)
21. [Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial].
Kruszewski J; Kłos K; Sułek K
Pol Merkur Lekarski; 2006 Nov; 21(125):443-8. PubMed ID: 17345837
[TBL] [Abstract][Full Text] [Related]
22. Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines.
Gillard M; Benedetti MS; Chatelain P; Baltes E
Inflamm Res; 2005 Sep; 54(9):367-9. PubMed ID: 16273334
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin.
Denham KJ; Boutsiouki P; Clough GF; Church MK
Inflamm Res; 2003 Oct; 52(10):424-7. PubMed ID: 14520518
[TBL] [Abstract][Full Text] [Related]
24. BRET-based β-arrestin2 recruitment to the histamine H1 receptor for investigating antihistamine binding kinetics.
Bosma R; Moritani R; Leurs R; Vischer HF
Pharmacol Res; 2016 Sep; 111():679-687. PubMed ID: 27468652
[TBL] [Abstract][Full Text] [Related]
25. Mutational analysis of the histamine H1-receptor binding pocket of histaprodifens.
Bruysters M; Pertz HH; Teunissen A; Bakker RA; Gillard M; Chatelain P; Schunack W; Timmerman H; Leurs R
Eur J Pharmacol; 2004 Mar; 487(1-3):55-63. PubMed ID: 15033376
[TBL] [Abstract][Full Text] [Related]
26. Discovery of the novel and potent histamine H1 receptor antagonists for treatment of allergic diseases.
Chu Z; Cen L; Xu Q; Lin G; Mo J; Shao L; Zhao Y; Li J; Ye W; Fang T; Ren W; Zhu Q; He G; Xu Y
Eur J Med Chem; 2024 Mar; 268():116197. PubMed ID: 38368709
[TBL] [Abstract][Full Text] [Related]
27. Anti-inflammatory activity of H1-receptor antagonists: review of recent experimental research.
Gelfand EW; Appajosyula S; Meeves S
Curr Med Res Opin; 2004 Jan; 20(1):73-81. PubMed ID: 14741075
[TBL] [Abstract][Full Text] [Related]
28. Effects of first and second generation antihistamines on muscarinic induced mucus gland cell ion transport.
Liu H; Farley JM
BMC Pharmacol; 2005 Mar; 5():8. PubMed ID: 15790419
[TBL] [Abstract][Full Text] [Related]
29. Comparative antiallergic effects of second-generation H1-antihistamines ebastine, cetirizine and loratadine in preclinical models.
Llupià J; Gras J; Llenas J
Arzneimittelforschung; 2003; 53(2):93-7. PubMed ID: 12642964
[TBL] [Abstract][Full Text] [Related]
30. Antiallergic effects of H1-receptor antagonists.
Baroody FM; Naclerio RM
Allergy; 2000; 55 Suppl 64():17-27. PubMed ID: 11291777
[TBL] [Abstract][Full Text] [Related]
31. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 2nd communication: lack of central nervous system and cardiovascular effects.
Kreutner W; Hey JA; Chiu P; Barnett A
Arzneimittelforschung; 2000 May; 50(5):441-8. PubMed ID: 10858871
[TBL] [Abstract][Full Text] [Related]
32. Brain histamine H
Nakamura T; Hiraoka K; Harada R; Matsuzawa T; Ishikawa Y; Funaki Y; Yoshikawa T; Tashiro M; Yanai K; Okamura N
Pharmacol Res Perspect; 2019 Aug; 7(4):e00499. PubMed ID: 31338198
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of HeLa cells to evaluate inverse agonistic activity of antihistamines.
Mizuguchi H; Ono S; Hattori M; Sasaki Y; Fukui H
Int Immunopharmacol; 2013 Mar; 15(3):539-43. PubMed ID: 23453703
[TBL] [Abstract][Full Text] [Related]
34. Desloratadine and loratadine stand out among common H
Fritz I; Wagner P; Broberg P; Einefors R; Olsson H
Acta Oncol; 2020 Sep; 59(9):1103-1109. PubMed ID: 32459128
[TBL] [Abstract][Full Text] [Related]
35. [Oral second generation antihistamines in allergic rhinitis].
Riechelmann H
Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
[TBL] [Abstract][Full Text] [Related]
36. Second-generation antihistamines for the treatment of chronic idiopathic urticaria.
Belsito DV
J Drugs Dermatol; 2010 May; 9(5):503-12. PubMed ID: 20480793
[TBL] [Abstract][Full Text] [Related]
37. Comparative efficacy of levocetirizine, desloratidine and fexofenadine by histamine wheal suppression test.
Dhanya NB; Thasleem Z; Rai R; Srinivas CR
Indian J Dermatol Venereol Leprol; 2008; 74(4):361-3. PubMed ID: 18797058
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine.
Schroeder JT; Schleimer RP; Lichtenstein LM; Kreutner W
Clin Exp Allergy; 2001 Sep; 31(9):1369-77. PubMed ID: 11591186
[TBL] [Abstract][Full Text] [Related]
39. Effect of H1-antihistamines on histamine release from dispersed canine cutaneous mast cells.
García G; DeMora F; Ferrer L; Puigdemont A
Am J Vet Res; 1997 Mar; 58(3):293-7. PubMed ID: 9055977
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.
Govoni M; Bakker RA; van de Wetering I; Smit MJ; Menge WM; Timmerman H; Elz S; Schunack W; Leurs R
J Med Chem; 2003 Dec; 46(26):5812-24. PubMed ID: 14667234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
